According to FutureWise analysis the market for dialysis concentrates is expected to reach US$ 4.75 billion by 2031 at a CAGR of 5.6%.
Dialysis concentrates are the fluids consists of purified water, glucose and electrolytes. The concentration of electrolytes (besides potassium and the buffer substance) closely resembles that which occurs naturally in the blood. Dialysis fluid is prepared according to the individual patient’s needs to help regulate their electrolyte and acid–base balance and remove metabolic waste products. There are primarily two types of concentrates for haemodialysis: bicarbonate (base) and acid. Acid and bicarbonate are mixed with treated water which then forms the dialysis fluid (dialysate). Hemodialysate is the solute and fluid that flows through the dialyzer during the process of haemodialysis. Once the acid concentrate, water and bicarbonate concentrate are combined. The final dialysate can contain up to 3 buffer components. These components depend on the amount of acid concentrate used.
According to 10% of the world, population is affected by chronic kidney diseases and over 2 million people receive dialysis every year. Of this 2 million, 80% of the procedure is conducted in the US, Germany, Japan, Brazil and Italy and the rest of the world accounts 20% of the procedural volume. Because of this, there is a huge demand for dialysis in middle-income countries. Further, increasing prevalence of chronic kidney disorders led to the robust growth of the market. It is further augmented by increasing demand dialysis for effective management of kidney disorders boosted the adoption among end users. According to WHO, 2.6 million people received dialysis globally in 2010 and it is estimated that the number will be double by 2030. Further, the growing financial burden led to the development of effective treatment strategies focused toward better management. Dialysis is one such effective method for disease management over alternative treatment strategies.
Global market is dominated by the US, Germany, Japan, Brazil, and Italy. The US is the major stakeholder in North America due to high adoption of dialysis. North America represents major stakeholder in the global market and it is followed by Europe. Europe is dominated by Germany, Italy, UK, and France due to high prevalence. Further, changing economic conditions in the Asia Pacific is expected to fuel the growth of the market. It is majorly dominated by Japan, China and India due to a large number of the patient population. Latin America and Rest of World is a fast growing region in the global market due to increasing penetration of dialysis in end-user segment.